New drug combinations could improve therapies for breast cancer, other aggressive cancers
OHSU study finds drug combinations slow progression of the cancer and lead to cancer regression.
Research
More Research Stories
- Latest Stories
OHSU experts caution older adults on increasing rates of dangerous falls
September 15, 2022
Ground-level falls among older adults can be reduced with awareness, simple measures, OHSU experts say.
Social media outreach for veteran suicide prevention shows promise
September 14, 2022
OHSU, VA study demonstrates feasibility of online training for at-risk veterans’ families, friends.
OHSU experts tapped for national Artificial Intelligence initiative
September 13, 2022
NIH-backed projects will help accelerate the use of artificial intelligence, machine learning to tackle complex research challenges for cancer, other diseases.
Study raises red flags about corporatization of health care, OHSU investigator says
September 02, 2022
Changes in patient volume, billing after private equity firms acquire physician practices.
OHSU supports research collaboration identifying genes linked to autism
September 01, 2022
Latest findings show differences in genetic influences among people across the autism spectrum.
Counseling is effective in preventing obesity for middle-aged women
August 23, 2022
OHSU researchers recommend focusing discussions on healthy eating and physical activity to maintain weight or limit weight gain.
Study to explore why COVID can also lead to obesity, diabetes
August 16, 2022
OHSU leading $2.5 million, two-year study in nonhuman primates.
Meth use drives overdose epidemic in rural U.S. communities
August 15, 2022
Study reveals methamphetamine use is common, contributes to the national overdose epidemic in rural America.
A better roadmap for beating a deadly leukemia
August 09, 2022
Using massive data set, OHSU researchers zero in on potential drug target to stop acute myeloid leukemia.
OHSU advancing first-of-its-kind strategy to overcome infertility
August 05, 2022
Grant award from Open Philanthropy advances proof of concept in mouse study.